The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Jul. 14, 2015
Applicant:

Sentreheart, Inc., Redwood City, CA (US);

Inventors:

Gregory W. Fung, Redwood Shores, CA (US);

Russell A. Seiber, Redwood City, CA (US);

Robert Strasser, Mountain View, CA (US);

Arnold M. Escano, San Jose, CA (US);

Ryan Douglas Helmuth, Saratoga, CA (US);

Assignee:

SentreHEART, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/24 (2006.01); A61N 7/02 (2006.01); A61B 18/18 (2006.01); A61B 17/12 (2006.01); A61B 17/122 (2006.01); A61B 17/00 (2006.01); A61B 18/02 (2006.01); A61B 18/00 (2006.01); A61N 7/00 (2006.01); A61M 25/01 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1492 (2013.01); A61B 17/122 (2013.01); A61B 17/12013 (2013.01); A61B 17/12122 (2013.01); A61B 17/12131 (2013.01); A61B 18/1815 (2013.01); A61B 18/24 (2013.01); A61N 7/022 (2013.01); A61B 17/12136 (2013.01); A61B 17/12172 (2013.01); A61B 17/12195 (2013.01); A61B 18/02 (2013.01); A61B 2017/00084 (2013.01); A61B 2017/00243 (2013.01); A61B 2017/00247 (2013.01); A61B 2017/00477 (2013.01); A61B 2017/00876 (2013.01); A61B 2018/00279 (2013.01); A61B 2018/00357 (2013.01); A61B 2018/00363 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/1407 (2013.01); A61B 2018/1861 (2013.01); A61M 25/0127 (2013.01); A61N 7/00 (2013.01); A61N 7/02 (2013.01);
Abstract

Described here are systems and methods for affecting tissue within a body to form a lesion. Some systems comprise tissue-affecting devices, devices that guide the advancement of the tissue-affecting elements to a target tissue region, devices that locate and secure tissue, and devices that help position the tissue-affecting devices along the target tissue. The methods described here comprise advancing a first tissue-affecting device to a first surface of a target tissue, advancing a second tissue-affecting device to a second surface of the target tissue, and positioning the first and second devices so that a lesion may be formed in the tissue between them. In some variations, the devices, systems, and methods described here are used to treat atrial fibrillation by ablating fibrillating tissue from an endocardial surface and an epicardial surface of a heart. Methods of closing, occluding, and/or removing the left atrial appendage are also described.


Find Patent Forward Citations

Loading…